Cwestiwn ysgrifenedig WQ89064
- Gofynnwyd gan
- Russell GeorgeCeidwadwyr
- I'w ateb gan
- Minister for Health and Social Services
- Cyflwynwyd
- Dyddiad ateb
- Atebwyd
- Amser i'w ateb
- 7 diwrnod
Cwestiwn
Mae'r cwestiwn a'r ateb yn Saesneg gan nad oes fersiwn Gymraeg ar gael.
What action is the Welsh Government taking in the immediate term, beyond optometry reform, to ensure those at highest risk of irreversible sight loss are seen in a clinically appropriate timeframe?
Ateb
Atebwyd gan Minister for Health and Social Services
The Welsh Government remains committed to reducing waiting times for the people of Wales and to reducing the risk of sight loss and irreversible harm. In my Ministerial Ophthalmology Summit in November 2022, I was very clear on my expectations that we cannot do more of the same and expect different results. Health boards must look to work differently, making use of the technology available to them and working together across health board boundaries and regions. The summit report can be found here.
I was very clear of the actions I wanted to see following the summit and a follow up summit is being planned. I commissioned a National Clinical Strategy for Ophthalmology to identify how the Pyott report recommendations will be made and sought detail on:
• demand, capacity, activity and backlog positions,
• workforce and training in Ophthalmology,
• Infrastructure and pathways to ensure services become most sustainable and
• Reduction of long waiting times.
While we have seen progress made in reducing long waiters achieving the eye care measures remains a challenge.
Over two-year waits have reduced from 9,300 in March 2022 to 2,385, a 74% improvement as of June 2023. Performance against the eye care measures however remains challenging with 49.3% of patients being seen within their due date in June 2023. This is a decrease of 0.3% since March 2022.
With the longer-term strategy work focussing on the future model of eye care in Wales, the Ophthalmology Clinical Implementation Network (CIN) is focusing on the shorter to medium term improvements. This work will be supported by the results of the Getting it Right First-Time (GiRFT) reviews of Glaucoma and Cataract to ensure pathways are delivered based on clinical evidence, ensuring safe and efficient practice.
The results of the reviews will link to the optometry reform allowing for the maximum use of total resources freeing up clinical urgency slots for those with the greatest clinical need.
As you indicate, you are already aware of the work underway to reform optometry through implementation of a new optometry contracted terms of service, which I announced in September last year. The emphasis is on more treatment and care delivered in the community.
The overarching focus of optometry contract reform is centred on alleviating pressure on secondary care hospital eye services. We are increasing the range of services delivered closer to home in primary care optometric practices, where there is a skilled workforce with the capacity to meet the predicted substantial increase in demand. Moving the delivery of some eye care services from hospitals to primary care optometry, represents the most viable and sustainable solution.